Protecting Access to Affordable Medicines Act of 2020
Latest action · Oct 6, 2020 Referred to the House Committee on Energy and Commerce.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedOct 6, 2020
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Protecting Access to Affordable Medicines Act of 2020
This bill prohibits additional rebates for certain drugs under the Medicaid Drug Rebate Program. Specifically, the bill prohibits additional rebates with respect to noninnovator multiple-source drugs (i.e., generics) for which the average manufacturer price is less than $1.
Cosponsors 6
Members who signed on, in the order they did. Signatures ran from Oct 6, 2020 to Dec 9, 2020, with 2 there on the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-MO | Billy Long | Original | Oct 6, 2020 |
| D-CA | Tony Cárdenas | Original | Oct 6, 2020 |
| D-AZ | Tom O'Halleran | Oct 20, 2020 | |
| D-FL | Darren Soto | Oct 27, 2020 | |
| R-WV | David B. McKinley | Oct 30, 2020 | |
| R-NC | Dan Bishop | Dec 9, 2020 |
Actions 2
Everything that happened, newest first.
- Oct 6, 2020Introduced in House
- Oct 6, 2020Referred to the House Committee on Energy and Commerce.
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Oct 6, 2020Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.